Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • AIOCD threatens to...

    AIOCD threatens to Boycott CIPLA if it enters into E-Pharmacy Business

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-31T14:35:27+05:30  |  Updated On 19 Dec 2022 5:33 PM IST

    New Delhi: A lobby of 8.5 lakh chemists across the country is planning to boycott the products manufactured by Cipla if the company enters the e pharmacy business reportedly with Bengaluru-based Medlife.


    According to a recent media report, All India Organisation of Chemists and Druggists (AIOCD) fretted after learning that Cipla is in conversation with online healthcare platform, Medlife to invest Rs 150-170 crore in the e pharmacy business.


    Over the past years, the business of chemist stores has been reeling under the pressure of trade margin regulation after the Government granted permission to e-pharmacies, in order to save supply chain costs and expecting to curb down the prices of medicines by 15-30 per cent.


    Last year, the powerful lobby of chemists across the country observed a strike to protest against the Government's decision to permit the online sale of drugs.


    Also Read: Opposing Online Pharmacies, 8.5 lakh chemists to call it a strike on September 28


    The AIOCD had been opposing e-pharmacies, stating that they are illegal as the Drugs & Cosmetics Act do not permit the online sale of drugs and with the latest report of Cipla and Medlife collaborating to back e pharmacy business further infuriated the chemists across the country.


    Speaking to Medical Dialogues, Rajiv Singhal, general secretary of the All India Organisation of Chemists and Druggists (AIOCD) stated that if at all Cipla collaborates with MedLife, the body and its members will stop promoting the products manufactured by the pharmaceutical company.


    Cipla manufactures top-selling brands such as Asthalin and popular painkiller Ibugesic. Sidelining of the products by chemists will apparently affect the business of the firm, thereby reducing the offline sale.


    AIOCD is awaiting confirmation from Cipla about the reports. If confirmed, the lobby will discuss the matter with its state heads to formulate its strategy.


    Also Read: Chemist license suspended for selling MTP pills sans prescription

    AIOCDAll India Organisation of Chemists and DruggistsBengaluruChemistCiplaCollaboratione-pharmacye-phrmacyepharmacyHealthcaremedicineMedlifeOnline Pharmacyonline saleonline sale of drugspharmapharma newspharma news indiaPharmaceuticalspharmacistTie Up
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok